Tunisian Clinical Registry on Hypoparathyroidism and Pseudo-hypoparathyroidism

Launched by DACIMA CONSULTING · May 31, 2024

Keywords

ClinConnect Summary

Endocrinologists from both sectors (public and private) are participating in the study. Data will be captured electronically by DACIMA Clinical Suite, according to FDA 21 CFR part 11 (Food and Drug Administration 21 Code of Federal Regulations part 11), HIPAA (Health Insurance Portability and Accountability Act) \& ICH (International Conference on Harmonisation) requirements.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Hypoparathyroidism defined by low serum calcium \< 2.2 mmol/l (\< 88 mg/l) associated with inadequate PTH (low or normal) and normal creatinine
• Exclusion Criteria:
• • Cervical surgery \< 6 months.
• • Transient (neonatal, etc.) or functional (dysmagnesemia, etc.) hypoparathyroidism.
• • Other causes of hypocalcemia: vitamin D deficiency, chronic renal failure, etc.
• • Familial hypocalcemia hypercalciuria.
• • Pseudo-pseudo-hypoparathyroidism.

Trial Officials